Apparent beneficial effects of tamoxifen on bone mineral content in patients with breast cancer: Preliminary study-Reference-Cited by-同舟云学术

Apparent beneficial effects of tamoxifen on bone mineral content in patients with breast cancer: Preliminary study

Published:1991-01 Issue:1 Volume:2 Page:39-41
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporosis Int

Author:

Ryan W. G.,Wolter J.,Bagdade J. D.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/BF01627077.pdf

Reference16 articles.

1. Early Breast Cancer Trialists' Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer; an overview of 61 randomized trials among 28 896 women. N Engl J Med 1988; 319:1681–92.

2. Fisher B, Costantino J. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen receptor positive tumors. New Engl J Med 1989; 320:479–84.

3. Baum M, Brinkely DM, Dossett JA. Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Analysis at six years by Nolvadex Adjuvant Trial Organization. Lancet 1985; i:836–9.

4. Jordan VC, Fritz NF, Tormey DC. Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on nodepositive patients with breast cancer. Cancer Res 1987; 47:624–30.

5. Wakley GK, Baum BL, Hannon KS et al. The effects of tamoxifen on the osteopenia induced by sciatic neurotomy in the rat: a histomorphometric study. Calcif Tissue Int 1988; 43:383–8.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective Estrogen Receptor Modulators (SERMs) and Selective Androgen Receptor Modulators (SARMs);Nuclear Receptors: From Structure to the Clinic;2015

2. Female Sex Hormones, Contraceptives, And Fertility Drugs;Burger's Medicinal Chemistry and Drug Discovery;2010-09-15

3. Calmodulin-an often-ignored signal in osteoclasts;Annals of the New York Academy of Sciences;2010-04

4. Bone health in postmenopausal women with early breast cancer: How protective is tamoxifen?;Cancer Treatment Reviews;2007-10

5. Developments in the pharmacotherapeutic management of osteoporosis;Expert Opinion on Pharmacotherapy;2006-07-28